Results 1 to 2 of 2

Thread: Beijing Declaration of International Association of Neurorestoratology (IANR)

  1. #1

    Beijing Declaration of International Association of Neurorestoratology (IANR)

    Beijing Declaration of International Association of Neurorestoratology (IANR)

    - Version Beijing 2009 -

    Adopted by the 2nd IANR Annual Conference General Assembly, Beijing, China, April 26, 2009
    Proposed by

    Hongyun Huang (China) President, International Association of Neurorestoratology; President, Beijing Hongtianji Neuroscience Academy; Chairman, Department of Neurosurgery Beijing Rehabilitation Center; Director & Prof., Neuroscience Institute of Taishan Medical University

    Geoffrey Raisman (UK) FRS, Advisor Board member, International Association of Neurorestoratology; Prof., Neural Regeneration at University College London; Director, the Spinal Repair Unit at the Institute of Neurology

    Wagih S El Masri (UK) Consultant Surgeon in Spinal Injuries. Director, Midlands Centre for Spinal Injuries RJ & AH Orthopaedic Hospital Oswestry Shropshire; Advisor Board Member, International Association of Neurorestoratology


    Dajue Wang (UK) Advisor Board member, International Association of Neurorestoratology; Project Advisor, Spinal Cord Repair, Institute of Neurosciences, Beijing; Editorial Board Member of Spinal Cord

    Tiansheng Sun (China) Vice-President, International Association of Neurorestoratology; Vice president of Beijing Army General Hospital; Prof. & Chair, Orthopedic Department, Beijing Army General Hospital

    Enzhong Liu (China) Vice-President, International Association of Neurorestoratology; Director & Prof., Neurosurgical Institute of Haerbin Medical University

    Huancong Zuo (China) Vice President, Medical College of Tsinghua University & President, Yuquan Hospital of Tsinghua University; Prof. Neurosurgical Department

    Changman Zhou (China) Prof., Department of Anatomy & Embryo, Peking University Health Science Center; Vice- President, the Chinese Society of Anatomical Sciences; Vice-Editor-in-Chief, ACTA Anatomica Sinica; Editor of Clinical Anatomy (USA)

    Lin Chen (China) Secretary General, International Association of Neurorestoratology; Vice-Chairman, Department of Neurosurgery, Beijing Rehabilitation Center; Associate Prof., Neuroscience Institute of Taishan Medical University

    Michael Chopp (USA) Vice Chairman, Research of the Department of Neurology, Henry Ford Health Systems; Zoltan J. Kovacs chair in Neuroscience Research, and Distinguished Professor, Physics at Oakland University

    Almudena Ramon-Cueto (Spain) Head of the Laboratory of Neural Regeneration Institute of Biomedicine, Valencia, Spanish National Research Council

    Albert Bohbot(France)Council Member, International Association of Neurorestoratology; Member, World Association for Laser Therapy; Member, World Academy for Laser Applications; Member of International Society for Quality of Care, Founder and director of Laboratory of research on the laserponcture®

    Ziad .M. Al Zoubi (Jordan) Consultant, Spinal and Ortho. Surgery; Secretary General, Pan Arab Spine Society; Chairman, World Spine Fellowship; Council Member, International Association of Neurorestoratology

    Klaus R.H. von Wild (Germany) Prof. of Neurosurgery Medical Faculty of the Westphälische Wilhelms-University Münster; Presidium of World Federation of Neurorehabilitation (WFNR) and Committee of Neurorehabilitation and Reconstructive Neurosurgery in World Federation of Neurological Surgery (WFNS)

    Robert M. Levy (USA) Prof., Neurological Surgery Feinberg School of Medicine Northwestern University, Chicago

    Eva Sykova (Czech) Prof. Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague

    Carlos Lima (Portugal) Prof., Neuropathology Laboratory Department of Neurology Hospital de Egas Moniz, Lisbon

    Patricia E. Phelps (USA) Prof., Department of Physiological Science and Brain Research InstituteUCLA, Los Angeles. CA

    Gerson Chadi (Brazil) Prof. & Director of Experimental Neurology Unit; Coordinator of the Neuroregeneration Research Center. Department of Neurology. University of Sao Paulo School of Medicine

    Chee-Pin CHEE (Malaysia)President, Asian Congress of Neurological Surgeons

    Elena Chernykh (Russia) Prof., Institute of Clinical Immunology, Siberian Division of the Russian Academy of Medical Sciences

    Debora R. Fior Chadi (Brazil) Associate Prof., Department of Physiology. Institute of Biosciences. University of São Paulo, SP Brazil

    Krystyna Domanska-Janik (Poland)Prof. NeuroRepair Dept; Medical Research Center. Polish Academy of Sciences, Warsaw, Poland

    Foo-Chiang LEE (Malaysia) FRACS Neurosurgeon, Dept of Neurosurgery Sunway Medical Center, Malaysia

    Gustavo Moviglia (Argentina) Prof., Immunology and Cellular Therapy. Maimonides University Buenos Aires – Argentina; Council Member, International Association of Neurorestoratology

    Yoon Ha (Korea) Assistant Prof., Department of Neurosurgery, Yonsei University College of Medicine, Seoul, Korea

    Russell J Andrews (USA) Ames Associate (Smart Systems and Nanotechnology) ; NASA Ames Research Center, Moffett Field, CA, USA

    Milan Dimitrijevic (USA & Slovenia) Emeritus Prof., Baylor College of Medicine, Houston, Texas, USA; Sr. Science Consultant to the University Institute of Clinical Neurophysiology, Ljubljana, Slovenia

    Paul R. Sanberg (USA) Associate Vice President for Research and Innovation; Distinguished University Prof. and Director, Center of Excellence for Aging and Brain Repair, University of South Florida; Vice-Chairman, Department of Neurosurgery, University of South Florida College of Medicine

    Mrabet. Abdelfattah (Tunis) President, the 5th Pan Arab Spine Congress; President, Tunisian Group of Spine cord Study and Research, Orthopedic Professor, Spine Surgeon

    Song Jianxing (Singapore) Associate Prof., Departments of Biochemistry and Biological Sciences, National University of Singapore.

    Wise Young (USA) Founding Director of the WM, Keck Center for collaborative Neuroscience and Richard H. Shindell Chair in Neuroscience, Rutgers, the state University of New Jersey, USA, Advisor Board Member, International Association of Neurorestoratology

    1. With rapid development of basic and clinical advancement on neural restoration, neurorestoratology has become a distinct discipline within neurosciences.

    2. World wide neurological impairment due to neurodegeneration and neural injury is a major factor reducing human longevity and quality of life. Neurorestoratology seeks therapeutic solutions to this problem.

    3. Neurorestoratology is the sub-discipline of neuroscience that studies neural regeneration, repair and replacement of damaged components of the nervous system, neuroplasticity, neuroprotection and neuromodulatory mechanisms of recovery. The goal of neurorestoratology is to promote recovery of neural function.

    4. The research and scope of neurorestoratology cover causes and treatments of neurotrauma, neurodegeneration, cerebrovascular anoxia or ischemia, edema, demyelination, sensory and motor disorders, and neuropathic pain, as well as neural damage resulting from toxic, physical and chemical factors, immune, infectious, inflammatory, hereditary, congenital, developmental, and other causes of neural injury.

    5. Neurorestorative therapies include regeneration and reconstruction of nervous tissues by transplantation of tissue, cells, or biomaterials and bioengineering, modulation by electro-magnetic stimulation, pharmaceutical or chemical therapies, and combinations of the above.

    6. Functional recovery is the objective of neurorestoratology, requiring close integration of neurorestorative and neurorehabilitative therapies, as well as the practice of clinical and preventative medicine to minimize complications of neural degeneration and damage.

    7. Neurorestoratology recognizes the importance of small functional gains that have significant effects on quality of life. Neurorestoratology is interested in the mechanisms of spontaneous activity and enhancing this recovery.

    8.Neurorestoratology supports the highest standards for clinical trials to evaluate the safety and efficacy of its neurorestorative therapies, the establishment of validated outcome measures, and ethical treatment of patients.

    9.The International Association for Neurorestoratology will develop guidelines for neurorestorative therapies, seek and encourage development of new therapies, promote multi-center collaboration, and will contribute to the training of people in the field.

    http://www.ianr.org.cn/English/new.asp?id=914

  2. #2
    6. Functional recovery is the objective of neurorestoratology, requiring close integration of neurorestorative and neurorehabilitative therapies, as well as the practice of clinical and preventative medicine to minimize complications of neural degeneration and damage.

Similar Threads

  1. Replies: 523
    Last Post: 05-30-2012, 04:15 PM
  2. Just 4 votes away from veto
    By wormie in forum Funding, Legislation, & Advocacy
    Replies: 25
    Last Post: 07-19-2006, 11:28 PM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •